Lightcast Discovery

Executive Summary

Lightcast Discovery is a UK-based biotechnology company founded in 2018 that is developing a next-generation platform for single-cell functional analysis. The platform enables precise interrogation of cellular heterogeneity, interactions, and functional behaviors at scale, addressing critical bottlenecks in drug discovery and diagnostics. By leveraging AI and machine learning, Lightcast aims to accelerate research and development across multiple therapeutic areas. The company's technology holds promise for improving our understanding of complex diseases and enabling more targeted therapies. Based in Cambridge, a global hub for biotech innovation, Lightcast is well-positioned to attract talent and partnerships. Despite being private and early-stage, the company has the potential to disrupt the single-cell analysis market, which is projected to grow significantly.

Upcoming Catalysts (preview)

• Q4 2026Series A Funding Round70% success
• Q2 2027Pharmaceutical Partnership for Drug Discovery60% success
• Q1 2027Commercial Launch of Platform50% success